Literature DB >> 18952901

Capsular localization of the Cryptococcus neoformans polysaccharide component galactoxylomannan.

Magdia De Jesus1, André Moraes Nicola, Marcio L Rodrigues, Guilhem Janbon, Arturo Casadevall.   

Abstract

Cryptococcus neoformans capsular polysaccharide is composed of at least two components, glucuronoxylomannan (GXM) and galactoxylomannans (GalXM). Although GXM has been extensively studied, little is known about the location of GalXM in the C. neoformans capsule, in part because there are no serological reagents specific to this antigen. To circumvent the poor immunogenicity of GalXM, this antigen was conjugated to protective antigen from Bacillus anthracis as a protein carrier. The resulting conjugate elicited antibodies that reacted with GalXM in mice and yielded an immune serum that proved useful for studying GalXM in the polysaccharide capsule. In acapsular cells, immune serum localized GalXM to the cell wall. In capsulated cells, immune serum localized GalXM to discrete pockets near the capsule edge. GalXM was abundant on the nascent capsules of budding daughter cells. The constituent sugars of GalXM were found in vesicle fractions consistent with vesicular transport for this polysaccharide. In addition, we generated a single-chain fraction variable fragment antibody with specificity to oxidized carbohydrates that also produced punctate immunofluorescence on encapsulated cells that partially colocalized with GalXM. The results are interpreted to mean that GalXM is a transient component of the polysaccharide capsule of mature cells during the process of secretion. Hence, the function of GalXM appears to be more consistent with that of an exopolysaccharide than a structural component of the cryptococcal capsule.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18952901      PMCID: PMC2620754          DOI: 10.1128/EC.00331-08

Source DB:  PubMed          Journal:  Eukaryot Cell        ISSN: 1535-9786


  31 in total

1.  Production and characterization of monoclonal antibodies specific for Cryptococcus neoformans capsular polysaccharide.

Authors:  T F Eckert; T R Kozel
Journal:  Infect Immun       Date:  1987-08       Impact factor: 3.441

2.  Experimental murine cryptococcosis: effect of hyperimmunization to capsular polysaccharide.

Authors:  M B Goren
Journal:  J Immunol       Date:  1967-05       Impact factor: 5.422

3.  A survey of heterobasidiomycetous yeasts for the presence of the genes homologous to virulence factors of Filobasidiella neoformans, CNLAC1 and CAP59.

Authors:  R Petter; B S Kang; T Boekhout; B J Davis; K J Kwon-Chung
Journal:  Microbiology       Date:  2001-08       Impact factor: 2.777

4.  Methods for the generation of chicken monoclonal antibody fragments by phage display.

Authors:  J Andris-Widhopf; C Rader; P Steinberger; R Fuller; C F Barbas
Journal:  J Immunol Methods       Date:  2000-08-28       Impact factor: 2.303

5.  Cryptococcus neoformans serotype A glucuronoxylomannan-protein conjugate vaccines: synthesis, characterization, and immunogenicity.

Authors:  S J Devi; R Schneerson; W Egan; T J Ulrich; D Bryla; J B Robbins; J E Bennett
Journal:  Infect Immun       Date:  1991-10       Impact factor: 3.441

6.  An anti-Cryptococcus neoformans monoclonal antibody directed against galactoxylomannan.

Authors:  A van de Moer; S L Salhi; R Cherniak; B Pau; M L Garrigues; J M Bastide
Journal:  Res Immunol       Date:  1990-01

7.  Galactoxylomannans of Cryptococcus neoformans.

Authors:  P G James; R Cherniak
Journal:  Infect Immun       Date:  1992-03       Impact factor: 3.441

8.  Capsular polysaccharides galactoxylomannan and glucuronoxylomannan from Cryptococcus neoformans induce macrophage apoptosis mediated by Fas ligand.

Authors:  Suellen N Villena; Roberta O Pinheiro; Carla S Pinheiro; Marise P Nunes; Cristina M Takiya; George A DosReis; José O Previato; Lucia Mendonça-Previato; Célio G Freire-de-Lima
Journal:  Cell Microbiol       Date:  2008-01-30       Impact factor: 3.715

9.  Antigenic characterization of Cryptococcus neoformans serotypes and its application to serotyping of clinical isolates.

Authors:  R Ikeda; T Shinoda; Y Fukazawa; L Kaufman
Journal:  J Clin Microbiol       Date:  1982-07       Impact factor: 5.948

10.  Facilitated isolation, purification, and analysis of glucuronoxylomannan of Cryptococcus neoformans.

Authors:  R Cherniak; L C Morris; B C Anderson; S A Meyer
Journal:  Infect Immun       Date:  1991-01       Impact factor: 3.441

View more
  29 in total

1.  Pleiotropic function of intersectin homologue Cin1 in Cryptococcus neoformans.

Authors:  Gui Shen; Amy Whittington; Kejing Song; Ping Wang
Journal:  Mol Microbiol       Date:  2010-03-16       Impact factor: 3.501

Review 2.  Emerging themes in cryptococcal capsule synthesis.

Authors:  Pardeep Kumar; Meng Yang; Brian C Haynes; Michael L Skowyra; Tamara L Doering
Journal:  Curr Opin Struct Biol       Date:  2011-09-01       Impact factor: 6.809

3.  Biogenesis of extracellular vesicles in yeast: Many questions with few answers.

Authors:  Débora L Oliveira; Ernesto S Nakayasu; Luna S Joffe; Allan J Guimarães; Tiago Jp Sobreira; Joshua D Nosanchuk; Radames Jb Cordero; Susana Frases; Arturo Casadevall; Igor C Almeida; Leonardo Nimrichter; Marcio L Rodrigues
Journal:  Commun Integr Biol       Date:  2010-11-01

4.  Exploring Cryptococcus neoformans capsule structure and assembly with a hydroxylamine-armed fluorescent probe.

Authors:  Conor J Crawford; Radamés J B Cordero; Lorenzo Guazzelli; Maggie P Wear; Anthony Bowen; Stefan Oscarson; Arturo Casadevall
Journal:  J Biol Chem       Date:  2020-01-31       Impact factor: 5.157

5.  Evidence for branching in cryptococcal capsular polysaccharides and consequences on its biological activity.

Authors:  Radames J B Cordero; Susana Frases; Allan J Guimaräes; Johanna Rivera; Arturo Casadevall
Journal:  Mol Microbiol       Date:  2011-01-05       Impact factor: 3.501

6.  Evaluation of Cryptococcus neoformans galactoxylomannan-protein conjugate as vaccine candidate against murine cryptococcosis.

Authors:  Siu-Kei Chow; Arturo Casadevall
Journal:  Vaccine       Date:  2011-01-14       Impact factor: 3.641

7.  Extracellular vesicles from Cryptococcus neoformans modulate macrophage functions.

Authors:  Débora L Oliveira; Célio G Freire-de-Lima; Joshua D Nosanchuk; Arturo Casadevall; Marcio L Rodrigues; Leonardo Nimrichter
Journal:  Infect Immun       Date:  2010-02-09       Impact factor: 3.441

8.  Characterization of yeast extracellular vesicles: evidence for the participation of different pathways of cellular traffic in vesicle biogenesis.

Authors:  Débora L Oliveira; Ernesto S Nakayasu; Luna S Joffe; Allan J Guimarães; Tiago J P Sobreira; Joshua D Nosanchuk; Radames J B Cordero; Susana Frases; Arturo Casadevall; Igor C Almeida; Leonardo Nimrichter; Marcio L Rodrigues
Journal:  PLoS One       Date:  2010-06-14       Impact factor: 3.240

9.  Identification of linear epitopes in Bacillus anthracis protective antigen bound by neutralizing antibodies.

Authors:  Nareen Abboud; Magdia De Jesus; Antonio Nakouzi; Radames J B Cordero; Mario Pujato; András Fiser; Johanna Rivera; Arturo Casadevall
Journal:  J Biol Chem       Date:  2009-07-18       Impact factor: 5.157

Review 10.  How sweet it is! Cell wall biogenesis and polysaccharide capsule formation in Cryptococcus neoformans.

Authors:  Tamara Lea Doering
Journal:  Annu Rev Microbiol       Date:  2009       Impact factor: 15.500

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.